Cybersecurity researchers have flagged a new technique that cybercriminals have adopted to bypass social media platform X’s malvertising protections and propagate malicious links using its artificial intelligence (AI) assistant Grok.
The findings were highlighted by Nati Tal, head of Guardio Labs, in a series of posts on X. The technique has been codenamed Grokking.
The approach is designed to get around restrictions imposed by X in Promoted Ads that allow users to only include text, images, or videos, and subsequently amplify them to a broader audience, attracting hundreds of thousands of impressions through paid promotion.
Threat actors have been exploiting a zero-day vulnerability in legacy Sitecore deployments to deploy WeepSteel reconnaissance malware.
The flaw, tracked under CVE-2025–53690, is a ViewState deserialization vulnerability caused by the inclusion of a sample ASP.NET machine key in pre-2017 Sitecore guides.
Some customers reused this key in production, allowing attackers with knowledge of the key to craft valid, but malicious ‘_VIEWSTATE’ payloads that tricked the server into deserializing and executing them, leading to remote code execution (RCE).
The French data protection authority has fined Google €325 million ($378 million) for violating cookie regulations and displaying ads between Gmail users’ emails without their consent.
During several investigations between 2022 and 2023, the National Commission on Informatics and Liberty (CNIL) found that Google’s Gmail email service displayed advertisements in the “Promotions” and “Social” tabs without the consent of Gmail users, thereby breaching Article L. 34–5 of the French Postal and Electronic Communications Code (CPCE).
As explained in a press release issued on Wednesday, this fine was imposed because Google breached the French Data Protection Act (Article 82) by failing to inform users who created new accounts that they were required to allow the search giant to place cookies for advertising purposes to access its services.
Google has released the September 2025 security update for Android devices, addressing a total of 84 vulnerabilities, including two actively exploited flaws.
The two flaws that were detected as exploited in zero-day attacks are CVE-2025–38352, an elevation of privilege in the Android kernel, and CVE-2025–48543, also an elevation of privilege problem in the Android Runtime component.
Google noted in its bulletin that there are indications that those two flaws may be under limited, targeted exploitation, without sharing any more details.
WARNING: AI could end humanity, and we’re completely unprepared. Dr. Roman Yampolskiy reveals how AI will take 99% of jobs, why Sam Altman is ignoring safety, and how we’re heading toward global collapse…or even World War III.
Dr. Roman Yampolskiy is a leading voice in AI safety and a Professor of Computer Science and Engineering. He coined the term “AI safety” in 2010 and has published over 100 papers on the dangers of AI. He is also the author of books such as, ‘Considerations on the AI Endgame: Ethics, Risks and Computational Frameworks’
He explains: ⬛How AI could release a deadly virus. ⬛Why these 5 jobs might be the only ones left. ⬛How superintelligence will dominate humans. ⬛Why ‘superintelligence’ could trigger a global collapse by 2027 ⬛How AI could be worse than nuclear weapons. ⬛Why we’re almost certainly living in a simulation.
00:00 Intro. 02:28 How to Stop AI From Killing Everyone. 04:35 What’s the Probability Something Goes Wrong? 04:57 How Long Have You Been Working on AI Safety? 08:15 What Is AI? 09:54 Prediction for 2027 11:38 What Jobs Will Actually Exist? 14:27 Can AI Really Take All Jobs? 18:49 What Happens When All Jobs Are Taken? 20:32 Is There a Good Argument Against AI Replacing Humans? 22:04 Prediction for 2030 23:58 What Happens by 2045? 25:37 Will We Just Find New Careers and Ways to Live? 28:51 Is Anything More Important Than AI Safety Right Now? 30:07 Can’t We Just Unplug It? 31:32 Do We Just Go With It? 37:20 What Is Most Likely to Cause Human Extinction? 39:45 No One Knows What’s Going On Inside AI 41:30 Ads. 42:32 Thoughts on OpenAI and Sam Altman. 46:24 What Will the World Look Like in 2100? 46:56 What Can Be Done About the AI Doom Narrative? 53:55 Should People Be Protesting? 56:10 Are We Living in a Simulation? 1:01:45 How Certain Are You We’re in a Simulation? 1:07:45 Can We Live Forever? 1:12:20 Bitcoin. 1:14:03 What Should I Do Differently After This Conversation? 1:15:07 Are You Religious? 1:17:11 Do These Conversations Make People Feel Good? 1:20:10 What Do Your Strongest Critics Say? 1:21:36 Closing Statements. 1:22:08 If You Had One Button, What Would You Pick? 1:23:36 Are We Moving Toward Mass Unemployment? 1:24:37 Most Important Characteristics.
NEW YORK and TRUMBULL, Conn., April 30, 2025 /PRNewswire/ — Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, and the Rett Syndrome Research Trust (RSRT), an organization working to cure Rett Syndrome, today announced a collaboration to license Apertura’s human transferrin receptor 1 capsid (TfR1 CapX). This partnership aims to advance innovative genetic medicine approaches for the treatment of Rett Syndrome, a rare genetic neurological disorder caused by random mutations in the MECP2 gene on the X chromosome that primarily affect females, causing developmental regression and severe motor and language impairments.
Apertura’s TfR1 CapX is an intravenously delivered adeno-associated virus (AAV) capsid engineered to bind the transferrin receptor 1(TfR1), enabling efficient delivery of genetic medicines across the blood-brain barrier (BBB). TfR1 is a well-characterized BBB-crossing receptor, broadly and consistently expressed throughout life—even in the context of neurological disease—making it an attractive target for CNS delivery in disorders like Rett syndrome. Developed by Apertura’s academic founder, Dr. Ben Deverman, Director of Vector Engineering at the Broad Institute, TfR1 CapX has shown strong CNS selectivity in preclinical studies, achieving over 50% neuronal and 90% astrocyte transduction across multiple brain regions. Because Rett syndrome affects the brain diffusely, broader cellular transduction may correlate with greater symptomatic improvement.
Students at ETH Zurich have developed a laser powder bed fusion machine that follows a circular tool path to print round components, which allows the processing of multiple metals at once. The system significantly reduces manufacturing time and opens up new possibilities for aerospace and industry. ETH has filed a patent application for the machine, and the results are published in the CIRP Annals.
Today, virtually all modern rocket engines rely on 3D printing to maximize their performance with tight coupling between structure and function. Students at ETH Zurich have now built a high-speed multi-material metal printer: a laser powder bed fusion machine that rotates the powder deposition and gas flow nozzles while it prints, which means it can process several metals simultaneously and without process dead time. The machine could fundamentally change the 3D printing of metal parts, resulting in significant reductions in production time and cost.
The team of six Bachelor’s students in their fifth and sixth semesters developed the new machine in the Advanced Manufacturing Lab under the guidance of ETH Professor Markus Bambach and Senior Scientist Michael Tucker as part of the Focus Project RAPTURE. In a mere nine months, the students realized, built and tested their idea. The machine is particularly aimed at applications in aerospace featuring approximately cylindrical geometries, such as rocket nozzles and turbomachinery, but is also of broad interest for mechanical engineering.
From flexible implants to circuits seeded with living cells, a new kind of electronics is starting to produce long-lasting implants with the potential to help everything from paralysis to hearing and vision loss
